Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric Rowinsky Insider Profile
4 Followers
Eric Rowinsky, CMO at Stemline Therapeutics, holds 20.63K shares in Biogen (Ticker: BIIB), holds 2.00K shares in Verastem (Ticker: VSTM), holds 68.80K shares in Fortress Biotech (Ticker: FBIO). Most recently, Eric Rowinsky Bought ― shares of Biogen on Feb 20, 2024 for an estimated value of 101.26K.
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
+14.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Eric Rowinsky holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric Rowinsky
Eric Rowinsky's Trading History
Stemline Therapeutics
Apr 28, 2015
―
Informative Sell
170.69K
$1.70M
Verastem
Jan 24, 2024
Director
Informative Buy
7.68K
$19.22K
Fortress Biotech
Jan 03, 2024
Director
Uninformative Buy
―
$124.52K
Biogen
Feb 20, 2024
Director
Informative Buy
101.26K
$3.99M
Navidea
Feb 22, 2018
Director
Uninformative Buy
―
$12.29K
DNIB Unwind, Inc.
Aug 30, 2016
―
Informative Buy
6.60K
$0.00
Savara
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Eric Rowinsky's performance on stock
You May Also Like
Eric Rowinsky insider profile FAQ
What is the percentage of profitable transactions made by Eric Rowinsky?
The percentage of profitable transactions made by Eric Rowinsky is 43%.
What is the average return per transaction made by Eric Rowinsky?
The average return per transaction made by Eric Rowinsky is 14.00%.
What stocks does Eric Rowinsky hold?
Eric Rowinsky holds: STML, VSTM, FBIO, BIIB, NAVB, BINDQ, SVRA stocks.
What was Eric Rowinsky’s latest transaction?
Eric Rowinsky latest transaction was an Informative Buy of $101.26K.
What was Eric Rowinsky's most profitable transaction?
Eric Rowinsky’s most profitable transaction was an Informative Sell of FBIO stock on April 9, 2021. The return on the trade was 77.00%.
What is Eric Rowinsky's role in Stemline Therapeutics?
Eric Rowinsky's role in Stemline Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.